The NIH, Clinical Center at Maryland campus, is currently recruiting participants for a Celexa/cipramil and Methylphenidate (Ritalin) trial on 7 to 17 year olds…Link.
The NIMH is also sponsoring the University of Michigan, Ann Arbor, Michigan, for a Sertraline/Zoloft trial on 7 to 19 year old, also recruiting…Link.
I have a 7 year old son. He is our baby, still very innocent, still believes in tooth fairies and santa claus and despite losing his idolised big brother, still amazingly secure and still loves us unconditionally! What would happen to this gorgeous little boy if zoloft, cipramil and/or ritalin was added to his brain? I had a 22 year old son who couldn’t handle 17 days on cipramil, so tell me, please, Who, in their right mind, thought this was a good idea since all 3 of these medications come with very strong suicide warnings from the FDA? Maybe it’s the NIMH executives who need a dose of their own strong medication, not a 7 year old or a teenager, and why did the FDA agree to these trials?
FDA…Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of major depressive disorder (MDD) and other psychiatric disorders.
All 3 of these medications come with a black box warning from the FDA. All 3 come with suicide warnings. Link.
- Chronic abusive use can lead to a marked tolerance and psychological dependence with varying degree of abnormal behavior
- Frank psychotic episodes can occur, especially with parenteral abuse (injected)
- Careful supervision required during drug withdrawal from abusive use since severe depression may occur. Link.
An interesting fact about the NIMH is the accusations of “conflict of interest” with the pharmaceutical industry. Senator Charles Grassley (R–Iowa), who led an investigation into the pharmaceutical industry’s influence, found several influential mental health researchers who received hundreds of thousands of dollars from pharmaceutical companies for tasks such as consulting work and education of psychiatrists, while simultaneously receiving government grants to study the very drugs those same companies make.
Dr. Pearson “Trey” Sunderland III, Chief of Geriatric Psychiatry at the National Institute of Mental Health, pled guilty to criminal conflict of interest.
As reported in The Lost Angeles Times , the admission of a criminal violation by Dr. Sunderland came after years of denials and six months after he pleaded the Fifth Amendment, asserting his constitutional right against self-incrimination to a Congressional committee. The prosecution was the first of an NIH scientist under federal conflict-of-interest laws in 14 years.
Dr. Sunderland faced up to a year in prison and a $100,000 fine for secretly contracting with Pfizer pharmaceuticals as a paid consultant for work that overlapped his duties as a full-time public servant. Dr. Sunderland was head of the Alzheimer’s research unit at NIMH. From 1998 to 2003, he received $285,000 in consulting fees from Pfizer pharmaceuticals (who introduced zoloft to the market) plus $15,000 in expenses. Link.
According to Pharmalot, at one point, NIMH director Tom Insel was ensnared in a probe by the US Senate Finance Committee.
What prompted this attention was a long-standing relationship with Charles Nemeroff, a former Emory University psychiatry department chair who accepted sizeable consulting fees from GlaxoSmithKline at the same time he was the primary investigator on an NIH-funded grant for research into a Glaxo drug.
The revelation sparked a probe by the US Department of Health and Human Services Office of Inspector General. Nemeroff subsequently left Emory and now works at the University of Miami. Link.
Thomas Insel, NIMH director, gave a plenary address to the Neuroethics Society entitled “Conflict of Interest in Psychiatry”.
Peter B. Reiner had this to say “While it was refreshing to have the director of NIMH speak to the challenges that conflict of interest pose, it was not lost on many audience members that this presentation seemed to be a bit of a mea culpa. More than one audience member remarked to me that Insel had been sullied by his minor role in l’affaire Nemeroff, where he made phone calls on behalf of his former Emory colleague Charles Nemeroff, a well-known psychiatrist who was negotiating for a new job after he lost his position at Emory over abusing conflict of interest rules”.
STILL THINK THEY HAVE CHILDREN’S BEST INTEREST AT HEART??
The NIH, GSK and Charles Nemeroff again in the papers! Penn psychiatrist alleges misconduct by colleagues. Link.